GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Current Accrued Expense

Australian Clinical Labs (ASX:ACL) Current Accrued Expense : A$0.0 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Current Accrued Expense?

Australian Clinical Labs's Current Accrued Expense for the quarter that ended in Dec. 2023 was A$0.0 Mil.


Australian Clinical Labs Current Accrued Expense Historical Data

The historical data trend for Australian Clinical Labs's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Current Accrued Expense Chart

Australian Clinical Labs Annual Data
Trend Dec20 Jun21 Jun22 Jun23
Current Accrued Expense
- - - -

Australian Clinical Labs Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Current Accrued Expense Get a 7-Day Free Trial - - - - -

Australian Clinical Labs Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Australian Clinical Labs Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Australian Clinical Labs (ASX:ACL) Business Description

Traded in Other Exchanges
N/A
Address
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines